Loperamide: a pharmacological review.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Reviews in gastroenterological disorders

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18192961
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loperamide: A Review of its Pharmacological Properties and Therapeutic Efficacy in Diarrhoea

  2012cited by this paper
• Pharmacological modulation of gut mucosal and large vessel blood flow

  2007cited by this paper
• Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort

  2007cited by this paper
• Relating protein pharmacology by ligand chemistry

  2007cited by this paper
• The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases

  2006cited by this paper
• Pharmacological Treatment of the Irritable Bowel Syndrome and Other Functional Bowel Disorders

  2006cited by this paper
• Treatment of irritable bowel syndrome.

  2005cited by this paper
• Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa.

  2005cited by this paper
• Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers

  2005cited by this paper
• Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

  2004cited by this paper
• Meta‐analysis: the treatment of irritable bowel syndrome

  2004cited by this paper
• Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels.

  2003cited by this paper
• Evaluation of drug treatment in irritable bowel syndrome.

  2003cited by this paper
• Pharmacologic Therapy for the Irritable Bowel Syndrome

  2003cited by this paper
• Interaction of Morphine, Fentanyl, Sufentanil, Alfentanil, and Loperamide with the Efflux Drug Transporter P-glycoprotein

  2002cited by this paper
• Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.

  2002cited by this paper
• Antipruritic and antihyperalgesic actions of loperamide and analogs.

  2002cited by this paper
• Management of the irritable bowel syndrome.

  2001cited by this paper
• Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance.

  2001cited by this paper
• Ritonavir increases loperamide plasma concentrations without evidence for P‐glycoprotein involvement

  2001cited by this paper
• Possible therapeutic use of loperamide for symptoms of lactose intolerance.

  2000cited by this paper
• Irritable bowel syndrome.

  2000cited by this paper
• Loperamide: novel effects on capacitative calcium influx

  2000cited by this paper
• Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

  2000cited by this paper
• Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.

  1999cited by this paper
• Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial.

  1999cited by this paper
• Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.

  1999cited by this paper
• Loperamide: a positive modulator for store-operated calcium channels?

  1997cited by this paper
• Influence of loperamide on lactose handling and oral–caecal transit time

  1996cited by this paper
• Loperamide

  1993cited by this paper
• Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity

  1992cited by this paper
• Safety and efficacy of loperamide.

  1990cited by this paper
• Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects.

  1984cited by this paper
• Loperamide: studies on its mechanism of action.

  1981cited by this paper
• Abuse potential of loperamide

  1980cited by this paper
• Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man.

  1974cited by this paper

• Assessment of Antidiarrheal Activity of Fraxin in Chick: Synergistic Effects and Molecular Docking Study

  2026cites this paper
• Kratom syrup reduces colitis severity and enhances intestinal barrier integrity in acetic acid-induced colitis mice

  2026cites this paper
• Bacterial constipation: Mucin-degrading intestinal commensal bacteria cause constipation.

  2026cites this paper
• Microscopic Colitis: Evidence-Based Guide to Diagnosis and Management.

  2026cites this paper
• Managing Drug–Drug Interactions Involving the Non‐Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling

  2026influential citation
• New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections

  2025cites this paper
• Beetroot leaf extract enhances gut motility in a model of loperamide‐induced constipation in male rats: A phytopharmacological study

  2025cites this paper
• Loperamide reverses 5-FU resistance in colorectal cancer by activating autophagy

  2025cites this paper
• Loperamide-induced constipation is associated with excessive accumulation of bile acids and cholesterol in the liver of mice; attenuation by hesperidin.

  2025cites this paper
• Evaluation of the Effect of Loperamide on the Cardiac Repolarization Interval Using Exposure–Response Analysis

  2025cites this paper
• Loperamide increases mouse gut transit time in a dose-dependent manner with treatment duration-dependent effects on distinct gut microbial taxa

  2025cites this paper
• Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control.

  2025cites this paper
• Filovirus infection disrupts epithelial barrier function and ion transport in human iPSC-derived gut organoids

  2025cites this paper
• Microbial metabolism of mannitol as a tracer for the non-invasive measurement of oral-cecal transit

  2025influential citation
• Novel strategies for combating colistin-resistant isolates: a review

  2025cites this paper
• Scrutinizing the antidiabetic, antidiarrheal, and anti-inflammatory activities of methanolic extract of pomegranate peel via different approaches

  2024cites this paper
• Peripherally mediated opioid combination therapy in mouse and pig.

  2024cites this paper
• Oral Administration of Ulva pertusa Kjellman Improves Intestinal Motility Against Loperamide-Induced Constipation in Mice

  2024cites this paper
• Management and Mechanisms of Diarrhea Induced by Tyrosine Kinase Inhibitors in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

  2024cites this paper
• CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer

  2024cites this paper
• Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission

  2024cites this paper
• Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care

  2024cites this paper
• The Risks of “Getting High” on Over-the-Counter Drugs during Pregnancy

  2024cites this paper
• Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents

  2024cites this paper
• Network pharmacology combined with an animal model to reveal the material basis and mechanism of Amomum villosum in alleviating constipation in mice.

  2023cites this paper
• Slow gut transit increases the risk of Alzheimer’s disease: An integrated study of the bi-national cohort in South Korea and Japan and Alzheimer’s disease model mice

  2023cites this paper
• Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study

  2023cites this paper
• Photoacoustic Imaging as a Novel Non-invasive Biomarker to Assess Intestinal Tissue Oxygenation and Motility in Neonatal Rats.

  2023cites this paper
• The Potential Mechanisms behind Loperamide-Induced Cardiac Arrhythmias Associated with Human Abuse and Extreme Overdose

  2023cites this paper
• New insight on the enteric cholinergic innervation of the pig colon by central and peripheral nervous systems: reduction by repeated loperamide administration

  2023cites this paper
• Antidiarrhoeal Activities of Lime (Citrus aurantiifolia) Extract in Experimentally-Induced Diarrhoea Model

  2023influential citation
• Special Populations-Surgical Infants.

  2023cites this paper
• Photoacoustic Imaging as a Novel Non-Invasive Biomarker to Assess Intestinal Tissue Oxygenation and Motility in Neonatal Rats

  2023cites this paper
• Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans—A Systematic Review and Treatment Guideline

  2023cites this paper
• Integrating omics and network pharmacology reveals the anti-constipation role of chitosan with different molecular weights in constipated mice.

  2023cites this paper
• Identification of a novel adjuvant loperamide that enhances the antibacterial activity of colistin against MCR-1-positive pathogens in vitro/vivo.

  2023cites this paper
• The Roots of Neorautanenia mitis (A. Rich) Verdcourt: Further Evidence of Its Antidiarrhoeal Activity

  2023cites this paper
• Cymbopogon citratus (DC.) Stapf aqueous extract ameliorates loperamide-induced constipation in mice by promoting gastrointestinal motility and regulating the gut microbiota

  2022cites this paper
• An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.

  2022cites this paper
• Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine.

  2022cites this paper
• Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity

  2022cites this paper
• Short Bowel Syndrome and Dysmotility.

  2022cites this paper
• Emerging therapies in the management of Irritable Bowel Syndrome (IBS)

  2022cites this paper
• Congenital sodium diarrhoea caused by rare de novo activating guanylate cyclase mutation

  2022cites this paper
• Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2

  2021cites this paper
• Irritable Bowel Syndrome in Pregnancy.

  2021cites this paper
• The different effects of Chinese Herb Solid Drink and lactulose on gut microbiota in rats with slow transit constipation induced by compound diphenoxylate.

  2021cites this paper
• Loperamide-Induced Torsades de Pointes

  2021cites this paper
• Whole whey stabilized oleanolic acid nanosuspension: Formulation and evaluation study

  2021cites this paper
• Formulation strategies to improve the efficacy of intestinal permeation enhancers.

  2021cites this paper
• Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome.

  2021cites this paper
• A Case Report of Torsade de Pointes and Brugada Pattern Associated with Loperamide Misuse and Supratherapeutic Loperamide Concentrations.

  2021cites this paper
• Loperamide Inhibits Replication of Severe Fever with Thrombocytopenia Syndrome Virus

  2021cites this paper
• Loperamide toxicity: recommendations for patient monitoring and management

  2020cites this paper
• REVIEW OF SOME TRADITIONAL HERBALS INCLUDED IN USADA TENUNG TANYA LARA AS DIARRHEA THERAPY AGENTS

  2020cites this paper
• Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions.

  2020cites this paper
• Ethnopharmacological Basis for Folkloric claims of Anagallis arvensis Linn. (Scarlet Pimpernel) as prokinetic, spasmolytic and hypotensive in province of Punjab, Pakistan.

  2020cites this paper
• The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

  2020cites this paper
• Loperamide exerts a direct bactericidal effect against M. tuberculosis, M. bovis, M. terrae and M. smegmatis

  2020cites this paper
• PROMISCUOUS 2.0: a resource for drug-repositioning

  2020cites this paper
• Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies

  2020cites this paper
• A simple automated approach to measure mouse whole gut transit

  2020cites this paper
• Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors.

  2020cites this paper
• Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse

  2020cites this paper
• Ileocecal Valve Removal Reverses the Constipating Effects of Loperamide in Rats.

  2020cites this paper
• Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series

  2020cites this paper
• Current Knowledge and Therapeutic Strategies of Herbal Medicine for Acute Diarrhea

  2020cites this paper
• Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets

  2020influential citation
• Left Ventricular Regional Wall Motion Abnormality in the Setting of Acute Loperamide Overdose

  2019cites this paper
• Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP‐mediated paraptosis‐like cell death

  2019cites this paper
• Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats

  2019cites this paper
• Wide interindividual variability in cardiovascular toxicity of loperamide: A case report and review of literature

  2019cites this paper
• Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)

  2019cites this paper
• Electroacupuncture via chronically implanted electrodes improves gastrointestinal motility by balancing sympathovagal activities in a rat model of constipation.

  2019cites this paper
• Loperamide: A Readily Available but Dangerous Opioid Substitute

  2019cites this paper
• Radiographic dose‐dependency study of loperamide effects on gastrointestinal motor function in the rat. Temporal relationship with nausea‐like behavior

  2019cites this paper
• New/emerging psychoactive substances and associated psychopathological consequences

  2019cites this paper
• Non-medical use of loperamide in the UK and USA.

  2019cites this paper
• Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report

  2019cites this paper
• Practice and Cases in Emergency Medicine Title

  2019cites this paper
• In Vitro to In Vivo Extrapolation of Pharmacokinetic Drug Interactions between Clarithromycin and Ranitidine with Trospium Chloride to Evaluate Probe Drug Characteristics for P-glycoprotein and Organic Cation Transporter Functions in Human Inauguraldissertation

  2019cites this paper
• A Heart-Wrenching Case of Loperamide Toxicity

  2019cites this paper
• Practice and Cases in Emergency Medicine Title Left Ventricular Regional Wall Motion Abnormality in the Setting of Acute Loperamide Overdose

  2019cites this paper
• Severe loperamide toxicity associated with the use of cimetidine to potentiate the “high”

  2018cites this paper
• Loperamide cardiotoxicity: “A Brief Review”

  2018cites this paper
• 4-Substituted and 1,4-Disubstituted Piperidines

  2018cites this paper
• Peripherally Acting &mgr;-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats

  2018cites this paper
• Progress in understanding mechanisms of opioid‐induced gastrointestinal adverse effects and respiratory depression

  2018cites this paper
• Gastrointestinal Exocrine (Lumencrine) Secretions. The Reception Theory as the Basis for Developing the First Antisecretory Pharmacotherapy Drugs

  2018cites this paper
• Redefining "bowel regimen": Pharmacologic strategies and nutritional considerations in the management of small bowel fistulas.

  2018cites this paper
• Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

  2018cites this paper
• miR-21 enhances the protective effect of loperamide on rat cardiomyocytes against hypoxia/reoxygenation, reactive oxygen species production and apoptosis via regulating Akap8 and Bard1 expression

  2018cites this paper
• Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk

  2018cites this paper
• Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon

  2018cites this paper
• Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity

  2018cites this paper
• Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

  2018cites this paper
• Antimicrobial and immunomodulatory activity induced by loperamide in mycobacterial infections

  2018cites this paper
• Bradycardia and Syncope in a Patient Presenting With Loperamide Abuse

  2018cites this paper
• Antidiarrheal Drug Therapy

  2017cites this paper
• “Poor man’s methadone” can kill the poor man. Extra-medical uses of loperamide: a review

  2017cites this paper